Physician profile
Mark Kaplan
NPI 1376649277
$28,632.53
in general payments reported to CMS, 2019-2025
13 companies · $4,321 in 2025
The $4,321 reported for 2025 was more than what 89% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,376 · 2020: $2,271 · 2021: $2,476 · 2022: $4,506 · 2023: $4,330 · 2024: $5,353 · 2025: $4,321.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $11K · Consulting Fee: $1,925 · Food and Beverage: $679.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $11,400.00 |
| Consulting Fee | $1,925.00 |
| Food and Beverage | $679.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $18,746.04 | 2019-2023 | Abthera Advance, 3m Cavilon, Prevena |
| Solventum Corporation | $9,342.49 | 2024-2025 | Prevena, Abthera Advance, Abthera |
| Baxter Healthcare | $165.13 | 2023-2024 | Perclot, Seprafilm |
| Boston Scientific Corporation | $155.91 | 2024 | |
| Integra Lifesciences Corporation | $83.68 | 2021-2023 | Integra, Integra Dermal Regeneration Template, Surgimend |
| Smith+Nephew, INC. | $29.65 | 2021-2025 | Collagenase Santyl |
| Vertex Pharmaceuticals Incorporated | $22.02 | 2025 | |
| Baudax Bio INC. | $20.99 | 2020 | |
| Ethicon US, LLC | $19.62 | 2023 | Surgicel Nu-Knit |
| Clovis Oncology, INC. | $14.66 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.29 | 2022 | |
| Janssen Biotech, INC. | $12.72 | 2019 | |
| Z-Medica, LLC | $5.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Kaplan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.